胺碘酮治疗阵发性室上性心动过速的临床观察(2)
![]() |
第1页 |
参见附件。
[参考文献]
[1] Ulla Walfridsson RN,Hakan Walfridsson MD.Impact of radiofrequencyablation on health-related Quality of life in patients with paroxysmalSupraventricular tachycardia compared with a norm Population one yearafter treatment[J].HEART and LUNG,2011,40(3):405-411.
[2] 黄凤荣,欧阳阳钢,徐姗,等.静脉注射胺碘酮与普罗帕酮治疗阵发性室上性心动过速的安全性及疗效[J].中国药业,2011,9(34):134-135.
[3] 王彦欧,徐凯,赵斌,等.合理应用胺碘酮治疗老年室性心律失常 66例疗效及安全性分析[J].中国医药导报,2011,8(11):154-155.
[4] 陈国柱,尤再春,李霞,等.三磷酸腺苷与普罗帕酮急诊转律阵发性室上性心动过速随机对照研究[J].重庆医学,2010,39(15):2015-2016,2019.
[5] Karpawich PP,Pettersen MD,Gupta P,et al.Infants andChildren with Tachycardia: Natural History and Drug Administration[J].Current Pharmaceutical Design,2008,14(8):743-752.
[6] 陈新谦.新编药物学[M].17版.北京:人民卫生出版社,2011:1.
[7] Palella FJ,Phair JP.Cardiovascular disease in HIV infection[J].Curr Opin HIV AIDS,2011,6(4):266-371.
[8] 吴新英.胺碘酮与心律平抗心律失常疗效比较的 Meta分析[J].广西医学,2004,26(2):241.
[9] Dilber E,Mutlu M,Dilber B,et al.Intravenous Amiodarone UsedAlone or in Combination with Digoxin for Life-ThreateningSupraventricular Tachyarrhythmia in Neonates and Small Infants[J].Pediatric Emergency Care,2010,26(2):82-84.
[10] Seiichiro Matsuo MD,Teiichi Yamane M.Acute progression ofcongestive heart failure during Paroxysmal supraventricular tachycardia ina patient Without structural heart disease[J].Journal of Cardiology Cases,2010,1(2):133-136.
[11] 黄凤荣,欧阳阳钢.静脉注射胺碘酮与普罗帕酮治疗阵发性室上性心动过速的安全性及疗效[J].中国临床医学,2011,9(34):134-135.
[12] 王少波,梁锦军,黄从新.静脉注射胺碘酮与普罗帕酮治疗阵发性室上性心动过速疗效的 Meta分析[J].疑难病杂志,2013,12(1):2-4.
(收稿日期:2013-12-20)
您现在查看是摘要介绍页,详见PDF附件。